Johnson & Johnson - Index

Johnson & Johnson - report - Index

PRINCIPAL OFFICE
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
(732) 524-0400
ANNUAL MEETING
The Annual Meeting of Shareholders will take
place April 24, 2008, at the Hyatt Regency
New Brunswick, 2 Albany Street, New
Brunswick, New Jersey. The meeting will
convene at 10 a.m. All shareholders are
cordially invited to attend. A formal Notice
of Meeting, Proxy Statement and Proxy have
been sent to shareholders.
CORPORATE GOVERNANCE
Copies of the Company’s 2007 Annual Report
on Form 10-K, Quarterly Reports on Form
10-Q and Current Reports on Form 8-K to
the Securities and Exchange Commission,
Proxy Statement, and this Annual Report are
available online at www.jnj.com, or to shareholders
without charge upon written request
to the Secretary at the Company’s principal
address or by calling (800) 328-9033
or (781) 575-2718 (outside the U.S.).
In addition, on the Company’s
Corporate Governance Web site at
www.investor.jnj.com/governance,
shareholders can see the Company’s
Principles of Corporate Governance,
Charters of the Audit Committee,
Compensation & Benefits Committee
and Nominating & Corporate Governance
Committee, Policy on Business Conduct
for employees and Code of Business
Conduct & Ethics for Members of the
Board of Directors and Executive Officers.
Copies of these documents are available to
shareholders without charge upon written
request to the Secretary at the Company’s
principal address.
C O R P O R A T E A N D S H A R E H O L D E R I N F O R M A T I O N
The Company is required to file as an
Exhibit to its Form 10-K for each fiscal year
certifications under Section 302 of the
Sarbanes-Oxley Act signed by the Chief
Executive Officer and the Chief Financial
Officer. In addition, the Company is required
to submit a certification signed by the Chief
Executive Officer to the New York Stock
Exchange within 30 days following the
Annual Meeting of Shareholders. Copies of
the certifications filed for previous years
are posted on the Company’s Corporate
Governance Web site, and future certifications
will be posted promptly upon filing.
COMMON STOCK
Listed on New York Stock Exchange
Stock Symbol JNJ
SHAREHOLDER RELATIONS CONTACT
Steven M. Rosenberg
Corporate Secretary
(732) 524-2455
INVESTOR RELATIONS CONTACT
Louise Mehrotra
Vice President, Investor Relations
(800) 950-5089
(732) 524-6492
TRANSFER AGENT AND REGISTRAR
Questions regarding stock holdings,
certificate replacement/transfer, dividends
and address changes should be directed to:
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
(800) 328-9033 or
(781) 575-2718 (outside the U.S.)
Internet: www.computershare.com
The paper used in this publication is made from
30% post-consumer recycled fiber, is Forest Stewardship
Council ® certified for chain of custody and was
manufactured with green energy credits for purchase
of electricity generated from renewable-energy sources
such as wind and low-impact hydro resources.
DIVIDEND REINVESTMENT PLAN
The Plan allows for full or partial
dividend reinvestment, and additional
monthly cash investments up to $50,000 per
year, in Johnson & Johnson common stock
without brokerage commissions or service
charges on stock purchases. If you are
interested in participating in the Plan and
need an authorization form and/or more
information, please call Computershare
Trust Company, N.A. at (800) 328-9033
or (781) 575-2718 (outside the U.S.).
HEARING IMPAIRED
Shareholders who have inquiries
regarding stock-related matters can
communicate directly with Computershare
Trust Company, N.A. via a telecommunications
device (TDD). The telephone number
for this service is (800) 952-9245
or (781) 575-2692 (outside the U.S.).
Registered shareholders who wish to
receive electronic notice of online access to
future annual reports and proxy materials
instead of paper copies may register online
at www.computershare.com/us/ecomms,
or www.econsent.com/jnj for employees
holding shares in one of the
Johnson & Johnson savings plans.
WEB SITE
www.jnj.com
For more information on
Johnson & Johnson history:
www.kilmerhouse.com
For the Johnson & Johnson
Web log: www.jnjbtw.com
© Johnson & Johnson 2008
THE FOLLOWING TRADEMARKS AND TRADE NAMES OF JOHNSON & JOHNSON AND ITS AFFILIATED COMPANIES APPEAR IN THIS REPORT:
1-DAY ACUVUE DEFINE, 1-DAY ACUVUE MOIST, ACCESS2WELLNESS, ACELERA, ACHIEVEVISION, ACIPHEX, ACTIV-FLEX, ACTIVE NATURALS, ACTIVE PHOTOBARRIER COMPLEX, ACUVUE,
ACUVUE ADVANCE, ACUVUE OASYS, ALTRX, AMBI, ANIMAS, AVEENO, BABYCENTER, BAND-AID, BEDTIME BATH, BEDTIME LOTION, BIOSENSE WEBSTER, BLISTER BLOCK, CARING FOR THE
WORLD. . . ONE PERSON AT A TIME, CARTOSOUND, CENTOCOR, CLEAN & CLEAR, CLEAN & CLEAR ADVANTAGE, CODMAN & SHURTLEFF, CONCERTA, CORDIS, CYPHER, DELTA XTEND,
DEPUY, DEPUY MITEK, DEPUY SPINE, DORIBAX, DOXIL, DURAGESIC, ECHELON, ENDOPATH, ENDOPATH DEXTRUS, EPREX, ETHICON, ETHICON ENDO-SURGERY, EVICEL, EVITHROM,
EZ STEER, FRONTRUNNER, GENESEARCH, GROUPE VENDOME, HALDOL, HARMONIC, HARMONIC FOCUS, HELIOPLEX, HYDRACLEAR, INTELENCE, INVEGA, IONSYS, JANSSEN, JANSSEN-
CILAG, JOHNSON & JOHNSON, JOHNSON’S, LACREON, LIFESCAN, LISTERINE, LISTERINE POCKETPAKS, LISTERINE TOOTH DEFENSE, LISTERINE WHITENING, LUBRIDERM, LTD, MAYA’S
MOM, NAVISTAR, NAVISTAR THERMOCOOL, NEUTROGENA, NEUTROGENA WAVE, NICORETTE, ONETOUCH, ONETOUCH ULTRAMINI, OROS, ORTHO BIOTECH PRODUCTS, ORTHO-
CLINICAL DIAGNOSTICS, ORTHO-MCNEIL, ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, OUTBACK, PARENTCENTER, PARIET, PEAK FX, PINNACLE, POSITIVELY AGELESS, PREZISTA,
PRINEO, PROCRIT, REACH, REALIZE, REMBRANDT, REMICADE, RETINOL CORREXION, RISPERDAL, RISPERDAL CONSTA, ROC, SOOTHING NATURALS, THE CAMPAIGN FOR NURSING’S
FUTURE, THE CAREGIVER INITIATIVE, THE VISION CARE INSTITUTE, THERAKOS, TIBOTEC, TOOTH DEFENSE, TOPAMAX, ULTAMET XL, VERIDEX, VERSALOK, XCEL
THE FOLLOWING TRADEMARKS AND TRADE NAMES OF OTHER COMPANIES ALSO APPEAR IN THIS REPORT:
American Dental Association, AmeriCares Direct Relief International, The Beijing Organizing Committee for the Games of the XXIX Olympiad, Bridge to Employment, DACOGEN (MGI
Pharma), DORIBAX (Shionogi & Co.), Forest Stewardship Council, HEMEDEX Q FLOW 500 (Hemedex, Inc.), Instituto de Desarollo Hondureno, International Olympic Committee IOC 2008,
MAP International, New England Journal of Medicine, Partnership for Prescription Assistance, Project HOPE, Safe Kids, Time, TOGETHER RX ACCESS, UNICEF, VELCADE (Millennium
Pharmaceuticals, Inc.), World Business Council for Sustainable Development, World Resources Institute, World Wildlife Fund, YONDELIS (PharmaMar)